Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia‐Activated Prodrug Tirapazamine Therapy for Metastatic Tumors is a research paper published in Advanced Materials (2019). On theSindex it has a DataRank of 0.806. It has been cited 215 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.806
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Ministry of Science and Technology of the People's Republic of China
Grant: 2016YFC1100701
Ministry of Science and Technology of the People's Republic of China
Grant: 2018ZX09711003‐012
Ministry of Science and Technology of China
Grant: 2018ZX09711003-012
National Natural Science Foundation of China
Grant: 51673189
National Natural Science Foundation of China
Grant: 51833010
National Natural Science Foundation of China
Grant: 51873206
National Natural Science Foundation of China
Grant: 51520105004
National Natural Science Foundation of China
Grant: 51673185
FWCI
11.05
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals